A review highlights the unique features of pediatric-type follicular lymphoma and its management, indicating distinct clinical significance.
Abstract Pediatric-type follicular lymphoma (PTFL) is a rare, indolent B-cell neoplasm accounting for <2% of all pediatric non-Hodgkin lymphomas. Recently recognized as a distinct entity, PTFL predominantly affects young males and typically presents as localized lymphadenopathy in the head and neck region. Histologically, PTFL shows nodal effacement by large, irregular follicles composed of intermediate-sized blastoid cells with germinal center phenotype. On a genetic level, PTFL lacks BCL2 rearrangements and shows recurrent mutations of MAP2K1 and TNFRSF14 genes. The disease has an excellent prognosis, with 5-year overall survival over 95% and extremely low progression rates. The management is usually conservative after complete surgical excision. In this review, we highlight the unique clinical-pathological and biological features of PTFL, with a focus on its differential diagnosis and on potential therapeutic approaches.
No takes yet. Share an insight, caveat, or question.
Dellea et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: